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Edited by Beat ImhofAbstract The Coxsackie and adenovirus receptor (CAR) is a
cell adhesion molecule that is highly expressed in the developing
brain. CAR is enriched in growth cone particles (GCP) after sub-
cellular fractionation. In GCP, we identiﬁed actin as an interac-
tion partner of the cytoplasmic domain of CAR. In vivo, actin
and CAR co-immunoprecipitate and co-localize. In vitro, the
binding is direct, with a Kd of 2.6 lM, and leads to actin bun-
dling. We previously demonstrated that CAR interacts with
microtubules. These data suggest a role for CAR in processes
requiring dynamic reorganization of the cytoskeleton such as
neurite outgrowth and cell migration.
 2007 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
Keywords: Coxsackie and adenovirus receptor; Actin;
Growth cone; Brain; Cytoskeleton1. Introduction
The Coxsackie and adenovirus receptor (CAR) is a cell
adhesion molecule of the immunoglobulin superfamily [1,2].
Full-length CAR has an amino-terminal V-like domain
(frequently referred to as D1), followed by a C2-like domain
(D2), a single membrane-spanning sequence, and a diﬀeren-
tially spliced cytoplasmic domain of either 107 residues (ending
in SIV) or 94 residues (ending in TVV) [1,3]. The extracellular
domain mediates homophilic cell adhesion [4–6] and ectopi-
cally-expressed CAR localizes to homotypic intercellular
contacts [6]. The intracellular domain of CAR is highly
conserved through species and although dispensible for adeno-
virus infection, it is required for the establishment of transepi-
thelial resistance [7] as well as the inhibition of glioma cell
migration and growth [8,9].
In the adult, CAR is mainly expressed on epithelial cells [10]
and is a component of the tight junction protein complex
[6,11]. During embryonic development, high levels of CAR
expression have been documented in the heart [12] and in the*Corresponding author. Address: Montreal Neurological Institute,
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doi:10.1016/j.febslet.2007.05.019nervous system [4,10,13]. In primary hippocampal cultures
prepared from embryonic mouse brain, CAR was shown to
be diﬀusely localized throughout the cell, including in the
growth cone region. These observations led Honda et al. to
suggest that CAR, as an adhesion molecule, may be involved
in network formation in the developing nervous system [4].
Since evidence is accumulating that CAR may be part of a sig-
naling complex, to start to understand the function of CAR in
the nervous system, we undertook a search for proteins that
interact with the cytoplasmic domain of CAR. Here we show
that CAR interacts with actin.2. Materials and methods
2.1. Isolation of growth cone particles (GPC)
GCPs were isolated by Ficoll gradient from brains of CD1 neonate
mice at post natal day 5 (P5) as described by Gordon-Weeks and
Lockerbie [14]. Minor modiﬁcation was made in that after the GCPs
were removed from interface between the sample and the 7% Ficoll,
they were then diluted 4 fold with the homogenization buﬀer
[10 mM HEPES, pH 7.4, 0.32 M sucrose, 1 mM MgCl2, and protease
inhibitor cocktail (1 tablet, Roche, Mississauga, Ont., Canada)] and
pelleted down at 39800 · gmax for 30 min at 4 C for subsequent as-
says.2.2. Immunoprecipitation
Isolated growth cone fractions were lysed in buﬀer containing
150 mM NaCl, 50 mM Tris–HCl, pH 7.4, 1% NP-40, and protease
inhibitor cocktail (1 tablet, Roche) by incubation on ice for 30 min.
After centrifugation at 3600 · gmax for 15 min at 4 C, the supernatant
was further centrifuged at 17500 · gmax for 30 min at 4 C. The insol-
uble pellet (which contained the majority of F-actin) was discarded and
the soluble supernatant was then incubated for 2 h at 4 C with protein
G-Sepharose beads (Pierce, Rockford, IL, USA) pre-coupled with 2 lg
of anti-b-actin antibody [Clone number ACTN05 (C4)] obtained from
Abcam (Cambridge, MA, USA). Beads were washed three times with
ice-cold lysis buﬀer and bound protein eluted with 2· Laemmli SDS–
PAGE loading buﬀer for Western blot analysis. Blots were incubated
with a polyclonal anti-CAR antibody [RP291] against the cytoplasmic
domain of CAR m1 isoform [15,16], a generous gift of Dr. Kerstin Sol-
lerbrant, Ludwig Institute, Karolinska Branch, Stockholm, Sweden.
The blot was then stripped and reblotted with a rabbit polyclonal anti-
body against actin (A2066, Sigma, Oakville, Ont., Canada).2.3. Fusion proteins
GST, GST-CAR and His-CARD fusion proteins were produced and
puriﬁed as described previously [9]. GST-N-Cadherin (amino acids
160–266) was puriﬁed similarly. When an eluted form was used for
in vitro actin binding, aﬃnity measurements, and bundling assays,blished by Elsevier B.V. All rights reserved.
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buﬀer (pH 8.0) containing 10 mM reduced glutathione, dialyzed for
48 h in general actin buﬀer and reconstituted with 10· actin polymer-
ization buﬀer before use.
2.4. GST pulldown assay and proteomic analysis
Growth cone fractions were lysed as described for the immunopre-
cipitation protocol. The lysates were then pre-cleared by incubating
with unbound glutathione–Sepharose beads, followed by GST-bound
glutathione–Sepharose beads (50 lL, 2 h each at 4 C under rotation)
to remove any non-speciﬁc binding. The pre-cleared lysates were
then incubated with 50 lL of GST-CAR-bound glutathione–
Sepharose beads for 2 h at 4 C, followed by washing three times with
lysis buﬀer. Interacting proteins were eluted with 2· Laemmli SDS–
PAGE loading buﬀer. Samples were electrophoresed on an 11%
SDS–polyacrylamide gel followed by silver staining for mass spectro-
scopic analysis as described previously [9], or transblotting for Western
blot analysis.2.5. F-actin preparation
Puriﬁed human platelet actin (100 lg) (Cytoskeleton Inc, Denver,
CO, USA) was diluted in 110 ll of general actin buﬀer (10 mM
Tris–HCl, pH 8.0, 0.2 mM CaCl2) and left on ice for 30 min. Actin
polymerization was induced by the addition of 12.2 ll of 10· actin
polymerization buﬀer (20 mM MgCl2, 10 mM ATP) and incubation
at room temperature (RT) for 1 h.
2.6. In vitro actin binding assays
Freshly prepared F-actin (40 ll) was incubated at RT for 1 h with
10 ll of 10 lg of test protein for a ﬁnal volume of 50 ll and layered
on top of 100 ll of cushion buﬀer (10 mM Tris–HCl, pH 8.0, 2 mM
MgCl2, 0.2 mM CaCl2, 1 mM ATP, 50% glycerol). F-actin and inter-Fig. 1. Identiﬁcation of actin as a CAR interacting protein in growth con
diﬀerential and gradient centrifugation, followed by blotting of the fractions
P1, nuclei and large debris; GCP, growth cone particles. (B) GCPs were used t
fusion protein followed by mass spectrometry. The peptides that were iso
(signiﬁcance set at >32). Peptide EEEIAALVIDNGSGMCK is speciﬁc to cacting proteins were pelleted by ultracentrifugation at 150000 · gmax
for 30 min at RT. 50 ll of the supernatant was gently removed from
the top of the tube for proteins not associated with F-actin pellets.
The F-actin pellets were collected after removing the remaining cush-
ion buﬀer by washing the bottom of the tube with 1· SDS–PAGE
loading buﬀer and analyzed by Western blotting. The membranes were
incubated with anti-actin (Sigma), anti-GST (Sigma) and anti-6-His
(Ab-1, clone 4D11; Lab Vision, Fremont, CA) antibodies or were
stained with Coomassie Blue. For peptide competition assays, F-actin
was preincubated with varying concentrations of peptides for 30 min at
RT. The CAR peptide (aa 340–365) was VAAPNLSRMGAVPVMI-
PAQSKD GSIV (MW: 2609; pI: 8.9). The control peptide was
CSSRGRNTPGKPMREDTMKLH (MW: 2401; pI: 10). After this
preincubation, GST-CAR fusion protein was added into the mixture
and incubated for 30 min as usual before the spindown.
2.7. F-actin binding aﬃnity measurements
These measurements were performed as described for the actin bind-
ing assays except that the amount of GST-CAR added varied from
0.62 lM to 19.75 lM. The amount of GST-CAR pelleted with F-actin
was quantitated by comparing the intensity of the bands against stan-
dard curves using the GeneTool software (Syngene, Frederick, MD,
USA). Constant F-actin quantity in the pellets of all of the samples
was also monitored using Western blot analysis. A dissociation curve
was constructed and the Kd calculated using Prism software (Graph
Pad, San Diego, CA, USA).
2.8. In vitro actin bundling assays
Freshly prepared F-actin (20 ll) was incubated at RT for 1 h with
test proteins at a ﬁnal concentration of 5 lM, 2.5 lM, 1.25 lM or
0 lM in a ﬁnal volume of 50 ll, after which the samples were centri-
fuged in a microfuge at 10000 · gmax for 30 min at RT and the pellet
and supernatant fractions analyzed by Western blotting. In some cases,e particles. (A). Brain tissue from neonate mice was fractionated by
for CAR and the growth cone marker GAP-43. H, Total homogenate;
o identify CAR-interacting proteins by aﬃnity binding with GST-CAR
lated after MS/MS analysis are boxed. The Mowse score was 471
-actin.
Fig. 2. CAR interaction with actin. (A) Neonate brain lysates were
applied to GST-Sepharose or GST-CAR, followed by immunoblotting
of the eluted material with an anti-b-actin antibody. b-actin was
detected only in the GST-CAR sample. (B) Neonate brain lysates were
immunoprecipitated using an anti-b-actin or a control IgG antibody,
followed by immunoblotting with a polyclonal antibody against the C-
terminus of CAR (RP291). CAR signal was detected only in the anti-
actin lane and not in the control IgG lane. * indicates IgG chains.
2704 K.-C. Huang et al. / FEBS Letters 581 (2007) 2702–2708samples were applied to a carbon-supported copper 300 mesh electron
microscope grid (Canemco Inc, Lakeﬁeld, QC, Canada), air dried, and
counter-stained with lead citrate and uranyl acetate for examinationFig. 3. Binding of CAR cytoplasmic domain to actin. (A) In vitro actin co-se
or GST-N-cadherin were incubated with polymerized F-actin (+Act, lanes 2,
The supernatant and pellet fractions were processed as described in Section 2
lane 2). GST-CAR was found in the pellet fraction only in the presence of
antibody in lanes 1 and 2 is a degradation product which does not contain ful
GST, His-CARD and GST-N-Cadherin were detected only in the supernata
performed with increasing concentrations of GST-CAR fusion protein adde
CAR bound to F-actin was quantiﬁed by immunoblotting with an anti-CA
Section 2. The experiment was repeated twice. (C) Peptide competition ass
terminus of CAR or an irrelevant control peptide were preincubated with F
Section 2. There was a dose dependent decrease in the amount of GST-
preincubation was performed in the presence of the CAR peptide. The expewith a JEOL (St-Hubert, Que., Canada) 100 CX transmission electron
microscope. The magniﬁcation used was 5000·.
2.9. Immunoﬂuorescence
Hippocampal cultures were prepared from embryonic day 17 mice as
described [17] and plated on poly-lysine coated coverslips. In some
cases, cultures at day in vitro 4 (DIV4) were live-treated for 1 h with
20 lM cytochalasin B (Sigma) in culture medium, ﬁxed (4% parafor-
maldehyde and 4% sucrose in PBS for 15 min), and immunostained
as described below. SH-SY5Y neuroblastoma cells (a kind gift of
Dr. J. Desbarats, McGill University) were plated in glass chamber
slides (Nunc, Rochester, NY, USA) and cultured in DMEM supple-
mented with10% fetal bovine serum (FBS). In some cases, the
SH-SY5Y cells were infected with recombinant adenovirus expressing
full-length CAR [AdCAR] (generated with the AdEasy system
[QBiogene, Montreal, Que., Canada]) or the control AdLacZ at a mul-
tiplicity of infection of 50. After 48 h incubation, cells were either ﬁxed
or diﬀerentiated for 48 h in the presence of culture medium supple-
mented with 100 lM retinoic acid (Sigma). For immunoﬂuorescence
analysis ﬁxed cells were blocked with 5% BSA (Sigma) and 5% Goat
serum (Invitrogen) in PBS for 24 h at 4 C, followed by incubation
with anti-CAR antibody (RP291; 1:6000 dilution) [16] in blocking buf-
fer overnight at 4 C. After three washes with 0.1% Tween-20/PBS,
coverslips were blocked and then incubated with ﬂuorochrome-
conjugated secondary antibody Alexa 555 goat anti-rabbit (Invitrogen)dimentation assays. GST-CAR, or GST protein, or His-tagged CARD,
4) or buﬀer alone (Act, lanes 1, 3) and then centrifuged at high-speed.
. Most of the F-actin was found in the pellet (lane 4 as compared with
actin (lane 4). [The faster migrating band detected with the anti GST-
l-length CAR, also does not bind actin and remains in the supernatant].
nt. (B) Saturation binding experiments. Co-sedimentation assays were
d to a constant concentration of polymerized F-actin. The amount of
R antibody to generate the saturation binding curve as described in
ays. A synthetic peptide containing the last 26 amino acids of the C-
-actin prior to carrying out the co-sedimentation assay as described in
CAR fusion protein recovered in the pellet fraction only when the
riment was repeated twice.
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luted at 1:250 and 1:40, respectively. After three washes with 0.1%
Tween-20/PBS, coverslips were mounted and images were collected
using a laser scanning confocal microscope (LSM 510, Carl Zeiss
MicroImaging Inc.) equipped with argon (488 nm) and krypton
(568 nm) lasers and a Plan Apochromat 63X/1.4 oil immersion objec-
tive lens.Fig. 4. Bundling of actin in vitro by the cytoplasmic domain of CAR.
(A) F-actin was incubated with GST or GST-CAR at diﬀerent
concentrations and then centrifuged at low speed as described in
Section 2. Most of F-actin remained in the supernatant in the presence
of GST. In the presence of increasing concentrations of GST-CAR,
there was an increase in the levels of F-actin recovered in the pellet. (B)
Negative stain electron microscopy images of samples prepared as
above (5000· magniﬁcation). In the presence of GST-CAR, bundles of
actin become evident. In contrast, in the presence of GST, no higher
order structures are seen.3. Results
We performed subcellular fractionation of brain homo-
genates prepared from neonate mice [post natal day 5 (P5)].
The crude synaptosomal fraction obtained by diﬀerential cen-
trifugation was further puriﬁed by Ficoll gradient centrifuga-
tion to isolate a fraction enriched in growth cones (Fig. 1A).
The degree of enrichment was veriﬁed by electron microscopy
(data not shown). Prior to incubation with a recombinant
GST-CAR fusion protein containing the cytoplasmic domain
of the mCAR1 isoform (amino acids 259–365), the growth
cone fraction was pre-cleared by sequential binding to glutathi-
one–Sepharose and GST-Sepharose. After elution and electro-
phoretic separation of the GST-CAR binding proteins,
proteomic analysis was performed on individual bands that
were enriched in the GST-CAR pull-downs as described in
Section 2. Mass spectrometry revealed highly signiﬁcant hits
with multiple peptides of actin (Fig. 1B), including one iso-
form-speciﬁc peptide (c-actin), consistent with the high expres-
sion of c-actin in the brain [18].
To conﬁrm the results of the proteomic analysis, we veriﬁed
that the GST-CAR fusion protein could pull down actin from
P5 brain homogenates. As shown in Fig. 2A, b-actin was de-
tected only in the samples that had been incubated with
GST-CAR fusion protein and was absent in samples incubated
with GST-Sepharose. To further establish the interaction of
CAR with actin, we immunoprecipitated b-actin from P5 brain
homogenates with an anti-actin monoclonal antibody and ana-
lyzed for the presence of CAR by Western blotting (Fig. 2B).
As compared to input sample, CAR was enriched in these
immunocomplexes.
To assess if CAR binds actin directly, in vitro co-sedimenta-
tion assays were performed with puriﬁed, polymerized F-actin
and recombinant GST-CAR fusion protein. During high-
speed centrifugation, GST-CAR was detected in the pellet
fraction only in the presence of F-actin (Fig. 3A). In contrast,
the GST recombinant protein remained in the supernatant
regardless of the presence or absence of F-actin (Fig. 3A). Sim-
ilarly, a control GST fusion protein (GST-N-Cad) expressing
the ectodomain 1 of N-cadherin (amino acids 160–266) did
not co-sediment with F- actin and remained in the supernatant
(Fig. 3A). Moreover, a His-tagged CAR fusion protein (encod-
ing amino acids 259–339) that was deleted in the most distal 26
amino acids of the cytoplasmic domain also failed to co-sedi-
ment with F-actin (Fig. 3A). A synthetic peptide encoding this
distal sequence competed with the binding of GST-CAR to F-
actin (Fig. 3C). Taken together, these experiments identify the
cytoplasmic domain of CAR as being capable of direct actin
binding. Using this assay, we performed saturation binding
experiments and determined CAR’s binding aﬃnity for F-actin
to have a dissociation constant of 2.6 lM (Fig. 3B), a value
that is comparable to the Kd of actin binding proteins such
as proﬁlin [19] and vinculin [20].To determine what impact the in vitro binding of GST-CAR
has on actin structure, we performed low-speed co-sedimenta-
tion assays. F-actin that had previously been incubated with
GST remained predominantly in the supernatant at these
low centrifugation speeds (Fig. 4A). However, in the presence
of increasing concentrations of GST-CAR, there was an in-
crease in the levels of F-actin recovered in the pellet, suggesting
that GST-CAR may cross-link actin ﬁlaments. These obser-
vations were corroborated by visualization of the actin-
GST-CAR bundles by negative stain electron microscopy
(Fig. 4B).
As CAR immunoreactivity has previously been detected in
growth cones of cultured hippocampal neurons, we determined
whether CAR co-localizes with F-actin in these structures. As
shown in Fig. 5A, CAR immunostaining and phalloidin stain-
ing coincide at the newly formed growth cones of mouse hip-
pocampal cultures at 2 days in vitro (DIV). Pharmacological
disruption of F-actin by treatment with cytochalasin B per-
turbed CAR localization, greatly decreasing CAR immunore-
activity that is typically observed along the processes, and
especially at the growth cone (Fig. 5B and C). Furthermore,
ectopic expression of CAR in SHSY-5Y neuroblastoma
cells also resulted in CAR co-localization with F-actin, both
in the ﬁlopodia of undiﬀerentiated cells, and in the pro-
cesses and growth cones following diﬀerentiation induced by
retinoic-acid (Fig. 6).
Fig. 5. Co-localization of CAR and actin in the growth cone of hippocampal neurons in culture. (A) DIV2 cultures were stained with the anti-CAR
antibody RP291 (red) and with ﬂuorochrome-conjugated phalloidin toxin to visualize F-actin (green). The bottom panel shows a merged image. (B,
C) DIV4 cultures were left untreated (B) or incubated with 20 lM cytochalasin B for 1 h (C) prior to ﬁxation and staining. In (C) the arrows indicate
the length of the processes as visualized by phase microscopy (top panel) and the corresponding points in the ﬂuorescent micrographs. Note that in
contrast to (B), there is greatly decreased signal at the growth cone either with phalloidin (middle panel) or anti-CAR antibody (bottom panel).
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CAR has a highly conserved intracellular domain, suggest-
ing that its cytoplasmic tail may have functional importance.
As CAR is highly expressed in the developing brain it may
participate in multiprotein complexes that are essential for
functions such as neurite outgrowth, pathﬁnding or target rec-
ognition. To identify CAR-interacting proteins, we performed
aﬃnity binding of the cytoplasmic domain of CAR with ex-
tracts prepared from growth cone fractions of mouse brain.
We show by co-immunoprecipitation and co-localization stud-
ies that CAR binds actin. Furthermore, at least in vitro, GST-
CAR manifests potent actin bundling activity. This may be
physiologically relevant as CAR probably exists as a dimer
in vivo [21], and this situation is recreated in vitro by the dimer-
ization of GST-CAR (through the GST moiety).
Changes in cell shape as well as regulated locomotion (neu-
rite outgrowth and growth cone pathﬁnding) necessitate reor-
ganization of the actin cytoskeletal system. Cell adhesionmolecules (CAM) play pivotal roles in these processes as they
can link the extracellular environment and the intracellular
cytoskeleton. Our ﬁnding of a direct CAR-actin interaction
is unique for a mammalian CAM expressed in developing
brain. However, this interaction is consistent with the general
function of CAMs in regulating dynamic reorganization of
the cytoskeleton [22,23]. For example, mammalian neural
adhesion molecules NCAM [24], L1 [25], and N-cadherin
[26] associate with and regulate the actin cytoskeleton,
although they do it indirectly through interaction with cyto-
plasmic actin binding proteins such as GAP-43, spectrin, anky-
rin, and b-catenin. While the present results suggest CAR may
regulate actin organization by direct binding, it is conceivable
that CAR may also be able to indirectly aﬀect actin cytoskel-
eton by associating with actin regulatory molecules.
We have previously shown that CAR interacts with micro-
tubules [9]. Our present data demonstrating an interaction of
CAR with actin in the developing brain supports the notion
of CAR as a cytoskeletal regulator, and suggests a role for
Fig. 6. Ectopically expressed CAR co-localizes with actin in neuroblastoma cells. As described in Section 2, SHSY-5Y neuroblastoma cells infected
with recombinant adenovirus expressing CAR were immunostained for CAR (red) or treated with phalloidin [F-actin, (green)] with or without prior
retinoic acid induced diﬀerentiation. Arrows indicate examples of areas of co-localization. Also shown are examples at higher magniﬁcation of the
merged image for the boxed areas. Note that not all cells are infected with the adenovirus (and thus are not immunostained by the CAR antibody
although they are visualized by phalloidin).
K.-C. Huang et al. / FEBS Letters 581 (2007) 2702–2708 2707CAR in processes requiring dynamic reorganization of the
cytoskeleton such as neurite outgrowth and growth cone path-
ﬁnding.
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